Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07304050 · ClinicalTrials.gov registry record · NA
Predicting ICU Transfers and Other Unforeseen Events (PICTURE)-Pediatric
A NA study of Clinical Deterioration, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 375
- Enrollment target
- 1
- Study location
NCT07304050: Recruiting NA study of Clinical Deterioration, sponsored by University of Michigan.
NCT07304050 is a NA study of Clinical Deterioration that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 375 participants, below the 14,401-participant average among 3 other Clinical Deterioration trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07304050, a NA study of Clinical Deterioration, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 375 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the effectiveness and user satisfaction of the study teams early warning system, called PICTURE, which utilizes artificial intelligence (AI) techniques and algorithms to identify patient deterioration on pediatric units within Mott Children's Hospital. In this pilot study the patient care team will review the PICTURE information and alerts. Morning rounds will be partially informed by the PICTURE scores and the scores will be included in the hand off notes for the patients with a red score. The primary purpose of this study is to test the hypothesis that the combination of the PICTURE-Pediatric model, the proposed workflow and the proposed interface results in at least 80% compliance. No participants will be consented as the Institutional review board has approved a waiver of consent for THE clinicians and the patients information being reviewed. The enrollment numbers will include only the clinicians.
Primary Outcome
Responses to the questions measure compliance with the workflow. Compliance will be measured as binary outcomes (i.e., compliant and noncompliant) and aggregated as a proportion.
Conditions Studied
Interventions
- DEVICE PICTURE-Pediatric scores and alerts
- OTHER Control Arm - Scores and alerts hidden
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2026-02-09 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT07304050 shows while recruiting
NCT07304050 is an interventional study that assigns participants to a tested intervention. The registered 375 participants enrollment target is mid-sized for trials with a published cap, below the 14,401-participant average among 3 other Clinical Deterioration trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Clinical Deterioration appearing as the primary indexed condition, and to 2 interventions - of which PICTURE-Pediatric scores and alerts is the first listed.
NCT07304050 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT07304050 about?
NCT07304050 is a clinical study titled "Predicting ICU Transfers and Other Unforeseen Events (PICTURE)-Pediatric". The purpose of this study is to evaluate the effectiveness and user satisfaction of the study teams early warning system, called PICTURE, which utilizes artificial intelligence (AI) techniques and algorithms to identify patient deterioration on pediatric units within Mott Children's Hospital. In th...
What is the current status of trial NCT07304050?
This trial is currently recruiting. It is a NA study. The enrollment target is 375 participants. The study started on 2026-02-09. Estimated completion is 2027-01.
What conditions does trial NCT07304050 study?
This clinical trial studies the following conditions: Clinical Deterioration.
What interventions are being tested in trial NCT07304050?
The interventions under investigation include: PICTURE-Pediatric scores and alerts (DEVICE), Control Arm - Scores and alerts hidden (OTHER).
Who is sponsoring clinical trial NCT07304050?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07304050 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clinical Deterioration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03686124 · 375 participants · Phase 1
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- NCT04059172 · 375 participants · Early Phase 1
Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management
- NCT04134923 · 375 participants
Imaging Biomarkers in Preclinical and Symptomatic AD
- NCT04569747 · 375 participants · Phase 2
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI